{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:20Z","timestamp":1786119260120,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:p>\n                    A 59-year-old woman with a history of recurrent pheochromocytoma underwent\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG and\n                    <jats:sup>18<\/jats:sup>\n                    F-octreotide PET\/CT to evaluate metastatic disease following progression on targeted therapy. FDG PET\/CT showed intense uptake in a mass in the right adrenal bed, bones, lung nodules, and lymph nodes. Octreotide PET\/CT confirmed concordant high uptake in the corresponding lesions. Germline testing revealed a VHL p.Asp126Asn mutation. This \u201cdual-tracer\u201d strategy provided complementary information on glucose metabolism and somatostatin receptor expression, facilitating prognostic stratification and therapeutic decision-making in VHL-mutated pheochromocytoma.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006497","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:00:10Z","timestamp":1777039210000},"page":"e809-e810","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Dual FDG and Octreotide PET\/CT Imaging in a Patient With Malignant Pheochromocytoma and VHL Gene Mutation"],"prefix":"10.1097","volume":"51","author":[{"given":"Qingyi","family":"Li","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Neijiang First People\u2019s Hospital, Neijiang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limeng","family":"He","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0192-5956","authenticated-orcid":false,"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Sichuan Provincial People\u2019s Hospital, University of Electronic Science and Technology of China, Chengdu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"R1-20260803","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"R2-20260803","doi-asserted-by":"crossref","first-page":"R293","DOI":"10.1530\/EC-21-0294","article-title":"Pheochromocytomas and paragangliomas in von Hippel-Lindau disease: not a needle in a haystack","volume":"10","author":"Castro-Teles","year":"2021","journal-title":"Endocr Connect"},{"key":"R3-20260803","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann Oncol"},{"key":"R4-20260803","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Ta\u00efeb","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R5-20260803","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1210\/endrev\/bnae001","article-title":"Imaging of pheochromocytomas and paragangliomas","volume":"45","author":"Timmers","year":"2024","journal-title":"Endocr Rev"},{"key":"R6-20260803","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1210\/clinem\/dgae252","article-title":"Approach to the patient: concept and application of targeted radiotherapy in the paraganglioma patient","volume":"109","author":"Pacak","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"R7-20260803","doi-asserted-by":"crossref","first-page":"e262","DOI":"10.1097\/RLU.0000000000006156","article-title":"All-in-one case: comprehensive detection of VHL syndrome with 68Ga-DOTATATE PET\/CT","volume":"51","author":"Nida","year":"2026","journal-title":"Clin Nucl Med"},{"key":"R8-20260803","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1200\/JCO-25-00791","article-title":"Phase II study of (177)Lu-DOTATATE for progressive metastatic pheochromocytomas and paragangliomas: interim analysis of efficacy, safety, and biomarkers","volume":"43","author":"Lin","year":"2025","journal-title":"J Clin Oncol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006497","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:47:24Z","timestamp":1786038444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006497","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"2025-12-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}